What is the name of the drug Novartis manufactures to treat chronic myeloid leukemia?
Gleevec
Exjade
Voltaren
Femara
Answer
Novartis manufactures a drug called imatinib mesylate, marketed as Gleevec or Glivec, which is used to treat chronic myeloid leukemia and other types of cancer.